Topical hemostatic and tissue-sealing agents in gynecologic surgery.
Cullifer RM, Makai G, Pacis M, Huynh T. Topical hemostatic and tissue-sealing agents in gynecologic surgery. Current Opinion In Obstetrics & Gynecology 2020, 32: 285-291. PMID: 32324712, DOI: 10.1097/gco.0000000000000632.Peer-Reviewed Original ResearchMeSH KeywordsAdministration, TopicalBlood Loss, SurgicalFemaleHemostasisHemostaticsHumansHysterectomyMinimally Invasive Surgical ProceduresUterine MyomectomyConceptsTopical hemostatic agentsGynecologic surgeryPotential complicationsShorter operating room timeHemostatic agent useSmall bowel obstructionBlood-borne pathogensOperating room timeMechanism of actionOvarian cystectomyAbdominal myomectomyBowel obstructionOvarian reserveBlood lossAbscess formationAllergic reactionsAgent useRoom timeSurgery proceduresHemostatic agentsSurgeryEfficacious useSurgical subspecialtiesTopical hemostaticsOperating timePreoperative Gabapentin for Minimally Invasive Hysterectomy: A Randomized Controlled Trial
Huynh TQ, Patel NR, Goldstein ND, Makai GE. Preoperative Gabapentin for Minimally Invasive Hysterectomy: A Randomized Controlled Trial. Journal Of Minimally Invasive Gynecology 2020, 28: 237-244.e2. PMID: 32389735, DOI: 10.1016/j.jmig.2020.04.040.Peer-Reviewed Original ResearchMeSH KeywordsAcetaminophenAdultAgedAnalgesics, OpioidCelecoxibDouble-Blind MethodDrug Administration ScheduleDrug Therapy, CombinationEnhanced Recovery After SurgeryFemaleGabapentinHumansHysterectomyMiddle AgedMinimally Invasive Surgical ProceduresNarcoticsPain MeasurementPain, PostoperativePreoperative PeriodUterine DiseasesConceptsPreoperative gabapentinTotal narcoticsPain scoresInvasive hysterectomyStudy armsAcademic-affiliated community hospitalAdverse effectsOral morphineGabapentin usePreoperative regimenSecondary outcomesControlled TrialsPrimary outcomeBenign indicationsSingle doseSurgical detailsControl armCommunity hospitalGabapentinSurgeryControl groupDemographic characteristicsNarcoticsHysterectomyWomen